logo
ResearchBunny Logo
Rule-based omics mining reveals antimicrobial macrocyclic peptides against drug-resistant clinical isolates

Medicine and Health

Rule-based omics mining reveals antimicrobial macrocyclic peptides against drug-resistant clinical isolates

Z. Cheng, B. He, et al.

Discover the cutting-edge research by Zhuo Cheng and colleagues, revealing new peptide antibiotics that combat antimicrobial resistance. This study identifies potent compounds like massatide A, effective against drug-resistant pathogens, showcasing a promising path for future antibiotic therapies.

00:00
00:00
Playback language: English
Abstract
Antimicrobial resistance is a critical global health threat. This paper reports the discovery of new aminovinyl-(methyl)cysteine (Avi(Me)Cys)-containing peptide antibiotics using a combined bioinformatic and experimental approach. Bioinformatic analysis of over 50,000 bacterial genomes identified 1172 biosynthetic gene clusters (BGCs) for Avi(Me)Cys-containing peptides. Three BGCs were linked to the biosynthesis of five peptide antibiotics, including massatide A, a class V lanthipeptide with potent activity against drug-resistant Gram-positive pathogens. Massatide A demonstrated efficacy in an animal infection model with a low resistance risk and favorable safety profile, making it a promising antibiotic candidate.
Publisher
Nature Communications
Published On
Jun 08, 2024
Authors
Zhuo Cheng, Bei-Bei He, Kangfan Lei, Ying Gao, Yuqi Shi, Zheng Zhong, Hongyan Liu, Runze Liu, Haili Zhang, Song Wu, Wenxuan Zhang, Xiaoyu Tang, Yong-Xin Li
Tags
antimicrobial resistance
peptide antibiotics
Avi(Me)Cys
biosynthetic gene clusters
massatide A
Gram-positive pathogens
safety profile
Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny